In line with these observations in AD patients, IFNγ immunostaining was highly enhanced in the cerebral cortex and dentate gyrus (DG) region of the hippocampus of APP/PS1 mice at 6 months of age when compared to WT C57BL/6 mice (Fig. 1B). Here, IFNG is linked to Alzheimer disease.